The research, led by physical therapists and scientists Hirotaka Iijima and Fabrisia Ambrosio of the Discovery Center for Musculoskeletal Recovery within the Department of Physical Medicine and Rehabilitation at Mass General Brigham, was published in the journal Nature Aging. The team set out to test a hypothesis that has been gaining traction in regenerative medicine: that circulating extracellular vesicles, or EVs, act as messengers through which exercise exerts its systemic effects on distant tissues. These nanoparticles, shed by cells throughout the body into the blood, are packed with proteins, lipids and RNA molecules that can alter the behavior of the cells they encounter.

Osteoarthritis is among the leading causes of pain, disability and loss of mobility in aging populations, and its prevalence is expected to climb as populations grow older. The disease involves the progressive breakdown of articular cartilage, the smooth, load-bearing tissue that cushions the ends of bones within joints. Once cartilage degrades, it has very limited capacity for self-repair, and current treatments largely manage symptoms rather than halt or reverse structural deterioration. Regular moderate exercise is strongly recommended for people with the condition and is known to protect joint tissue, but the molecular pathways translating a bout of physical activity into healthier cartilage have never been fully mapped.

The researchers designed their investigation to span multiple levels of biological organization, combining analyses of extracellular vesicles, cell culture experiments, mouse models of aging-associated osteoarthritis and a structured human exercise intervention. In the human portion of the study, older adults completed a three-month moderate-intensity aerobic exercise program. Blood samples were collected before the program began and again after the training period, allowing the team to compare the molecular contents of circulating EVs before and after sustained physical activity and to evaluate the biological effects of these exercise-derived vesicles on cartilage cells and joint tissues.

The results were striking. Moderate-intensity exercise significantly reshaped the cargo carried by circulating EVs in ways that promoted cartilage health and tissue resilience. When the researchers applied EVs collected from participants after exercise to cartilage cells and joint tissues in laboratory and animal settings, those vesicles improved cellular and tissue health in the knee joint. In other words, the blood of a person who had just completed months of aerobic training carried particles that could actively encourage cartilage cells toward a healthier state, a finding that reframes exercise not merely as mechanical conditioning but as a source of circulating therapeutic signals.

Among the molecular signals enriched in EVs after exercise training, one stood out: microRNA-29, a small regulatory RNA molecule. The team identified microRNA-29 as a key mediator of the beneficial effects, and when they delivered it directly to aged, osteoarthritic joints in their experimental models, the treatment restored more youthful characteristics in cartilage cells and reduced features associated with joint degeneration. This single microRNA, shuttled through the bloodstream inside exercise-altered vesicles, appears capable of nudging aged chondrocytes, the resident cells of cartilage, away from the degenerative patterns that characterize osteoarthritis and toward a healthier, more resilient phenotype.

The technical implications of this work are considerable. Extracellular vesicles have become a major focus of regenerative medicine because they can cross biological barriers, deliver their cargo to specific target cells and carry complex mixtures of signaling molecules that are difficult to reproduce with a single synthetic drug. By demonstrating that exercise naturally enriches circulating EVs with a cartilage-protective microRNA, the study provides a mechanistic bridge between rehabilitation science and molecular therapeutics. It suggests that the benefits of a supervised exercise program can, at least in part, be bottled in principle, raising the possibility of EV-based or microRNA-based therapies that reproduce the joint-protective effects of physical activity.

Such therapies would be especially meaningful for patients who cannot exercise sufficiently because of pain, disability or other health limitations. For a person with advanced knee osteoarthritis, the very activity that would protect their joints may be intolerably painful, creating a vicious cycle in which immobility accelerates degeneration. A treatment that harnesses the biological signals generated by exercise, without requiring the exercise itself, could break that cycle. The researchers note that these strategies would pair regenerative medicine with traditional rehabilitation principles, potentially guiding the design of clinical programs focused on maximizing the biological responses associated with joint protection and tissue health rather than relying on activity alone.

The study also carries a broader conceptual message about how the body responds to physical activity. Exercise has long been recognized to benefit organs far removed from the muscles doing the work, including the brain, heart, immune system and bone, and circulating extracellular vesicles are increasingly implicated as one of the communication channels behind these systemic effects. The Mass General Brigham findings extend that framework to cartilage, a tissue that lacks blood vessels of its own and was long thought to be largely insulated from systemic signals. The demonstration that vesicle-borne microRNA-29 can reach and rejuvenate aged chondrocytes suggests that cartilage is far more responsive to whole-body physiology than its isolated biology would imply.

For the investigators, both of whom trained as physical therapists, the work is animated by a deceptively simple question: why and how does exercise work? Much remains to be learned about why physical activity ranks among the most effective interventions for a wide range of musculoskeletal conditions, but this study represents a concrete step toward that understanding. By pinpointing a specific, exercise-regulated molecular signal that improves the health of aging cartilage cells, the research transforms an old clinical observation into a testable biological pathway, and it opens a realistic path toward treatments that could one day deliver the medicine of movement to patients whose bodies will no longer let them move.

Subject of Research: How exercise-derived extracellular vesicles and microRNA-29 protect aging cartilage in osteoarthritis

Article Title: Research Spotlight: Exercise as medicine—how exercise protects joints in aging-related osteoarthritis

Article References: Research Spotlight: Exercise as medicine—how exercise protects joints in aging-related osteoarthritis. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: osteoarthritis, exercise, extracellular vesicles, microRNA-29, cartilage, chondrocytes, aging, Nature Aging, regenerative medicine, joint health, physical therapy, Mass General Brigham

Extracellular vesicles, often called EVs, are lipid-enclosed nanoparticles shed by virtually every cell type in the body. Once dismissed as cellular garbage disposal, they are now recognized as a genuine intercellular communication system: they ferry proteins, lipids and nucleic acids between cells, and their cargo changes with physiological state. Exercise is a particularly powerful modulator of this cargo. Previous work has shown that the blood of trained individuals contains circulating exosomes with distinct microRNA profiles compared with sedentary controls, and that exercise-induced vesicles can protect the heart against ischemia-reperfusion injury and influence metabolic disease. What remained unknown, and what the new study set out to resolve, is precisely how the microRNA payload of exercise-primed vesicles is decoded by recipient cells in distant tissues, and which downstream genes translate that message into a measurable health benefit.

The researchers chose articular cartilage as their model tissue for good reason. Cartilage is avascular, poorly innervated and notoriously resistant to self-repair, and its degeneration underlies osteoarthritis, one of the most burdensome age-related diseases worldwide. The Global Burden of Disease Study 2021 projects that the number of people living with osteoarthritis will continue climbing toward 2050, and clinical guidelines already recommend exercise as first-line, non-surgical management. Yet cartilage cells, or chondrocytes, sit embedded in a dense matrix far from any blood vessel, making it biologically puzzling that a systemic intervention like jogging could improve their health at all. The answer, the study suggests, travels in vesicles small enough to cross the blood-joint barrier.

To find that answer, the team combined human intervention data with computational network biology. In a three-month aerobic exercise program involving older adults, the researchers isolated extracellular vesicles from participants’ plasma before and after the intervention and profiled their small RNA content by sequencing. An acute bout of exercise significantly altered sixteen vesicular microRNAs, and pathway analysis showed that these exercise-sensitive microRNAs predominantly targeted genes involved in cell-matrix adhesion, the molecular anchoring system by which chondrocytes sense and respond to their surrounding scaffold. Rather than testing each microRNA one by one, the team then used network propagation, a computational technique that simulates how a perturbation spreads through a tissue-specific gene interaction network, to predict the cumulative downstream effect of the altered microRNA cocktail on cartilage cells.

The network analysis delivered a strikingly clear verdict: the exercise-primed microRNA payload converged on pathways of cellular aging, with the microRNA-29 family emerging as the dominant regulator of the effect. This prediction was not merely statistical. When the researchers performed an in silico knockout of microRNA-29, the health-promoting signature of the exercise-primed vesicles was substantially attenuated, pinpointing this single microRNA family as a key node in the cartilage-aging regulatory network. The microRNA-29 family has an established track record in regenerative biology, with prior studies implicating it in the regulation of collagen expression, fibrosis and synovial inflammation, but its role as the exercise-responsive messenger that reprograms aged chondrocytes had not previously been appreciated.

The mechanistic core of the study concerns a gene with an almost legendary reputation in aging research: KL, which encodes the protein α-Klotho, named after the Greek Fate who spins the thread of life. The team’s earlier work had shown that age-related stiffening of the cartilage matrix epigenetically silences α-Klotho in chondrocytes through hypermethylation of the KL promoter, compromising cell integrity and pushing the cells toward a degenerative phenotype. In the new experiments, chondrocytes cultured on stiff, aged-like substrates recapitulated this pathological state, with altered cell morphology, compromised integrity and a hypermethylated KL promoter. When the researchers treated these cells with exercise-primed extracellular vesicles from the human participants, the vesicles epigenetically de-repressed KL, partially reversing the promoter hypermethylation, restoring α-Klotho expression and driving the chondrocytes back toward a more youthful, anabolic phenotype.

Causality was tested in two complementary ways. First, the researchers engineered extracellular vesicles to be enriched with microRNA-29 and showed that these synthetic packages reproduced the anabolic effects of the natural exercise-primed vesicles in aged human chondrocytes, and that this benefit depended on α-Klotho, confirming the KL gene as the functional target. MicroRNA-29 mimics also reduced the expression of Itgb1, a gene encoding an integrin subunit that was upregulated in chondrocytes on stiff substrates and identified among the leading-edge targets of the exercise-sensitive microRNAs. Second, and most importantly for translational relevance, the team injected exercise-primed extracellular vesicles directly into the knee joints of aged mice. The intra-articular administration mitigated age-related cartilage degeneration in the animals, demonstrating that the vesicle-mediated signal is not an artifact of cell culture but a physiologically meaningful intervention in a living, aging joint.

The implications ripple outward in several directions. For exercise science, the study provides the most complete mechanistic chain yet linking a behavioral intervention to epigenetic remodeling in a distal tissue: exercise alters circulating vesicular microRNA cargo, microRNA-29 de-represses KL, and α-Klotho restores chondrocyte health. For regenerative medicine, it suggests that extracellular vesicles could be harvested, engineered or pharmacologically primed to deliver microRNA-29 to damaged joints, potentially offering a disease-modifying therapy for osteoarthritis, a condition currently managed largely with pain relief and, eventually, joint replacement. The engineering approach also sidesteps some safety concerns associated with viral gene therapy, since vesicles are natural delivery vehicles, although the authors’ demonstration that the benefit is only partially dependent on α-Klotho hints that additional, still-unmapped pathways contribute to the overall effect.

Important caveats remain before microRNA-29-enriched vesicles reach the clinic. The human component of the study demonstrated that exercise raises vesicular microRNA-29 relative to each participant’s own baseline, but the therapeutic injections were performed in mice, and the dose, frequency and long-term safety of intra-articular vesicle therapy in humans are unknown. The network models, while powerful, are computational predictions that require continued experimental validation, and the heterogeneity of osteoarthritis, which includes post-traumatic as well as age-related forms, means that the microRNA-29-Klotho axis may not benefit every patient equally; indeed, the disease-enrichment analysis in the study pointed most strongly at primary, age-related knee osteoarthritis as the relevant clinical target. Still, the study marks a conceptual shift: exercise is revealed not merely as mechanical conditioning of load-bearing tissue but as a systemic signaling event, packaged into nanoparticles, written in microRNA, and read by aging cells as an instruction to switch a longevity gene back on. In that light, every aerobic workout becomes a dispatch of molecular medicine, and the challenge ahead is learning to bottle it.

Subject of Research: Exercise-primed extracellular vesicles enriched in microRNA-29 restore aged chondrocyte health through epigenetic derepression of the KL gene encoding α-Klotho

Article Title: Exercise enhances aged chondrocyte health through microRNA-29-enriched extracellular vesicles

Article References: Iijima, H., Dave, K. M., Wang, K., Khay, A. M., D’Amico, E., Tang, W.-Y., Rogers, R. J., Jakicic, J. M., & Ambrosio, F. (2026). Exercise enhances aged chondrocyte health through microRNA-29-enriched extracellular vesicles. Nature Aging. https://doi.org/10.1038/s43587-026-01225-9

Image Credits: AI Generated

DOI: 10.1038/s43587-026-01225-9

Keywords: extracellular vesicles, microRNA-29, exercise, chondrocytes, cartilage, α-Klotho, KL gene, epigenetics, osteoarthritis, aging, network biology, regenerative medicine